Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationlly. Its products include human albumin; intravenous human immunoglobulin; rabies patient immunoglobulin; tetanus human immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. The company was founded in 1966 and is headquartered in Beijing, China.
Metrics to compare | 600161 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600161PeersSector | |
|---|---|---|---|---|
P/E Ratio | 23.5x | 28.7x | −0.5x | |
PEG Ratio | 7.65 | −0.59 | 0.00 | |
Price/Book | 2.7x | 2.2x | 2.6x | |
Price / LTM Sales | 4.8x | 6.1x | 3.2x | |
Upside (Analyst Target) | 56.6% | 29.6% | 51.4% | |
Fair Value Upside | Unlock | 6.6% | 8.5% | Unlock |